Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate
Listen now
Description
What strategies are you using to individualize treatment of HR+/HER2- early breast cancer?
Credit available for this activity expires: 11/17/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998210?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer?
Credit available for this activity expires: 4/23/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000702?ecd=bdc_podcast_libsyn_mscpedu
Published 04/25/24
Published 04/25/24
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures:...
Published 04/25/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
